Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation and Geographic Spread
1.3.2 Inclusions & Exclusions
1.4 Years Considered
1.5 Currency Considered
1.6 Key Stakeholders

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Revenue Share Analysis Illustration
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
2.5.1 Methodology-Related Limitations
2.5.2 Scope-Related Limitations
2.6 Risk Assessment

4.1 Key Opportunities for Players in Ai in Pathology Market
4.2 Ai in Pathology Market: Regional Mix
4.3 Asia Pacific: Ai in Pathology Market, by End User and Key Country/Region
4.4 Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Development of Cnns and Advanced Ai Models
5.2.1.2 Integration of Ai Into Multiplex Imaging
5.2.1.3 Increasing Cases of Misdiagnoses in Patients
5.2.1.4 Benefits of Ai-Augmented Telepathology
5.2.1.5 Advancements in Deep Learning & Image Processing
5.2.2 Restraints
5.2.2.1 High Cost of Digital Pathology Systems
5.2.2.2 Limited Ai Expertise and Varied Regulatory Guidelines for Medical Software
5.2.2.3 Inadequate Interoperability Issues With Legacy Systems
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Personalized Medicines
5.2.3.2 Integration of Multi-Omics Data
5.2.3.3 Predictive Analytics for Disease Progression
5.2.4 Challenges
5.2.4.1 Insufficient Data for Ai Algorithms
5.2.4.2 Data Privacy and Ethical Concerns
5.2.4.3 Challenges Associated With Interpretability of Ai Models
5.3 Trends & Disruptions Impacting Customer Business
5.4 Industry Trends
5.4.1 Evolution of Ai in Pathology
5.5 Ecosystem Analysis
5.6 Value Chain Analysis
5.7 Technology Analysis
5.7.1 Key Technologies
5.7.1.1 Machine Learning (Ml) and Artificial Intelligence (Ai)
5.7.1.2 Computer Vision
5.7.2 Complementary Technologies
5.7.2.1 Cloud Computing
5.7.3 Adjacent Technologies
5.7.3.1 Telepathology
5.8 Regulatory Landscape
5.8.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.8.2 Regulations, by Region
5.8.2.1 North America
5.8.2.1.1 Us
5.8.2.1.2 Canada
5.8.2.2 Europe
5.8.2.3 Asia Pacific
5.8.2.3.1 Japan
5.8.2.3.2 China
5.9 Pricing Analysis
5.9.1 Average Selling Price Trend, by Region
5.9.2 Indicative Pricing Analysis, by Offering
5.10 Porter's Five Forces Analysis
5.10.1 Threat From New Entrants
5.10.2 Threat From Substitutes
5.10.3 Bargaining Power of Suppliers
5.10.4 Bargaining Power of Buyers
5.10.5 Intensity of Competitive Rivalry
5.11 Patent Analysis
5.11.1 Patent Publication Trends for Ai in Pathology Solutions
5.11.2 Jurisdiction and Top Applicant Analysis
5.12 Key Stakeholders and Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Buying Criteria
5.13 End User Analysis
5.13.1 Unmet Needs of End Users
5.13.2 End User Expectations
5.14 Key Conferences and Events, 2025-2026
5.15 Case Study Analysis
5.15.1 Case Study 1: Patbal Employed Pytorch for Its High-Level Pythonic Syntax to Support Diverse Modeling Approaches
5.15.2 Case Study 2: Kfbio Developed Kfbio Ai Cervical Cancer Screening System to Strengthen Cancer Diagnosis
5.15.3 Case Study 3: Research Team From University of Helsinki Used Aiforia Create to Develop Deep-Learning Ai Model to Predict Patient Outcomes
5.16 Investment & Funding Scenario
5.17 Business Models
5.18 Impact of Ai/Gen Ai on Ai in Pathology Market
5.18.1 Key Use Cases
5.18.2 Ai/Generative Ai Implementation: Case Study
5.18.2.1 Accelerated Biomarker Discovery and Clinical Trial Optimization
5.18.3 Impact of Ai/Gen Ai on Interconnected and Adjacent Ecosystems
5.18.3.1 Drug Discovery & Development Market
5.18.3.2 Medical Imaging & Diagnostics Market
5.18.4 User Readiness and Impact Assessment
5.18.4.1 User Readiness
5.18.4.1.1 Pharmaceutical Companies
5.18.4.1.2 Biopharmaceutical Companies
5.18.4.2 Impact Assessment
5.18.4.2.1 User a: Pharmaceutical Companies
5.18.4.2.1.1 Implementation
5.18.4.2.1.2 Impact
5.18.4.2.2 User B: Biopharmaceutical Companies
5.18.4.2.2.1 Implementation
5.18.4.2.2.2 Impact
5.19 Trade Analysis
5.19.1 Import Scenario
5.19.2 Export Scenario
5.20 Us 2025 Tariff
5.20.1 Introduction
5.20.2 Key Tariff Rates
5.20.3 Price Impact Analysis
5.20.4 Impact on Country/Region
5.20.4.1 Us
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 Impact on End Use Industries

6.1 Introduction
6.2 End-to-End Solutions
6.2.1 Increasing Demand for Integrated Workflows in Healthcare Models to Drive Market
6.3 Niche Point Solutions
6.3.1 Growing Focus on Precision Medicine and Targeted Therapy Research to Propel Market
6.4 Technology
6.4.1 Rising Need for Advanced Data Management Solutions to Fuel Market
6.5 Hardware
6.5.1 High Adoption of Ai-Based Microscopes to Propel Market
6.6 Microscopes
6.6.1 Need for Automated Analysis of Tissue Samples to Fuel Growth
6.7 Scanners
6.7.1 Improvements in Image Quality and Precision Diagnostics to Boost Demand
6.8 Storage Systems
6.8.1 Need for Structured Models of High-Resolution Images to Support Market Growth

7.1 Introduction
7.2 Convolutional Neural Networks (Cnns)
7.2.1 Focus on Providing High-Quality Image Recognition and Objection Detection to Propel Market
7.3 Generative Adversarial Networks (Gans)
7.3.1 Need for Generating Accurate Synthetic Pathology Images to Drive Market
7.4 Recurrent Neural Networks (Rnns)
7.4.1 Need for Analysis of Sequential Data and Time-Dependent Patterns to Fuel Market
7.5 Other Neural Networks

8.1 Introduction
8.2 Image Analysis
8.2.1 Detection of Cellular Anomalies and Disease Markers to Fuel Uptake
8.3 Diagnostics
8.3.1 Rapid Procession of Automated Samples to Drive Market
8.4 Workflow Management
8.4.1 Optimization of Lab Resources for High-Throughput Results to Fuel Uptake
8.5 Data Management
8.5.1 Emphasis on Advancements in Data Integration and Processing to Boost Demand
8.6 Predictive Analytics
8.6.1 Growing Focus on Early Diagnosis of Diseases to Drive Market
8.7 Cdss
8.7.1 Provision of Real-Time Insights to Fuel Market
8.8 Automated Report Generation
8.8.1 Increasing Demand for Quality Control to Drive Market
8.9 Quality Assurance Tools
8.9.1 Rising Regulatory Need to Accelerate Demand for Quality Assurance Tools to Boost Growth

9.1 Introduction
9.2 Drug Discovery
9.2.1 Target Identification & Selection
9.2.1.1 Analysis of Molecular and Histological Data for Biomarker Discovery to Fuel Market
9.2.2 Target Validation
9.2.2.1 Increasing Demand for Precision Medicines to Drive Market
9.2.3 Hit Identification & Prioritization
9.2.3.1 Growing Requirement for Rapid Analysis and Cost Efficiency to Fuel Uptake
9.2.4 Hit-to-Lead Identification
9.2.4.1 Advancements in Ml to Support Market Growth
9.2.5 Lead Optimization
9.2.5.1 Growing Focus on Therapeutic Efficacy to Propel Market
9.2.6 Candidate Selection & Validation
9.2.6.1 Critical Requirement for Regulatory Approvals to Drive Market
9.3 Disease Diagnosis & Prognosis
9.3.1 Increasing Incidence of Chronic Diseases to Fuel Market
9.4 Clinical Workflow
9.4.1 Structured Automation of Extensive Volume Data to Drive Market
9.5 Training & Education
9.5.1 Utilization of Digital Pathology Systems in Academic Institutes to Support Market Growth

10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.2.1 Growing Focus on Toxicology Testing to Propel Market
10.3 Hospitals & Reference Laboratories
10.3.1 Increasing Need for Effective Diagnoses of Infectious Diseases to Drive Growth
10.4 Academic & Research Institutes
10.4.1 Growing Investments in Life Sciences Research to Support Demand

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook
11.2.2 Us
11.2.2.1 High Healthcare Expenditure and Improvements in Cloud Computing Platforms to Propel Market
11.2.3 Canada
11.2.3.1 Increasing Adoption of Deep Learning for Advanced Healthcare Diagnostics to Drive Market
11.3 Europe
11.3.1 Macroeconomic Outlook
11.3.2 Uk
11.3.2.1 Increased Focus on Drug Discovery and Development to Boost Demand
11.3.3 Germany
11.3.3.1 Availability of Funding for Ai Initiatives to Fuel Uptake
11.3.4 France
11.3.4.1 Increasing Adoption of Big Data in Healthcare Computing to Fuel Uptake
11.3.5 Italy
11.3.5.1 Digital Transformation and Innovation in Healthcare to Support Market Growth
11.3.6 Spain
11.3.6.1 Increased Workforce Shortage to Fuel Market
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 Macroeconomic Outlook
11.4.2 China
11.4.2.1 Rising Cases of Infectious and Chronic Diseases to Fuel Demand
11.4.3 Japan
11.4.3.1 Advanced Healthcare Infrastructure to Propel Market
11.4.4 India
11.4.4.1 Growing Focus on Healthcare Digitization to Boost Demand
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook
11.5.2 Brazil
11.5.2.1 Strategic Investments for Ai Adoption to Support Market Growth
11.5.3 Mexico
11.5.3.1 Growth in Pharmaceutical R&D to Drive Market
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook
11.6.2 Gcc Countries
11.6.2.1 Increasing Investments for Expansion of Technological Expertise to Support Growth
11.6.3 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Strategies Adopted by Players in Ai in Pathology Market
12.3 Revenue Analysis, 2020-2024
12.4 Market Share Analysis, 2024
12.5 Company Evaluation Matrix: Key Players, 2024
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2024
12.5.5.1 Company Footprint
12.5.5.2 Offering Footprint
12.5.5.3 Use Case Footprint
12.5.5.4 End User Footprint
12.5.5.5 Region Footprint
12.6 Company Evaluation Matrix: Startups/Smes, 2024
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product/Service Launches & Approvals
12.9.2 Deals
12.9.3 Other Developments

13.1 Key Players
13.1.1 Koninklijke Philips N.V.
13.1.1.1 Business Overview
13.1.1.2 Products/Services Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Deals
13.1.1.4 The Analyst's View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses & Competitive Threats
13.1.2 F. Hoffmann-La Roche Ltd.
13.1.2.1 Business Overview
13.1.2.2 Products/Services Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product/Service Launches & Approvals
13.1.2.3.2 Deals
13.1.2.4 The Analyst's View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses & Competitive Threats
13.1.3 Hologic, Inc.
13.1.3.1 Business Overview
13.1.3.2 Products/Services Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product/Service Launches & Approvals
13.1.3.4 The Analyst's View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses & Competitive Threats
13.1.4 Akoya Biosciences, Inc.
13.1.4.1 Business Overview
13.1.4.2 Products/Services Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Deals
13.1.4.4 The Analyst's View
13.1.4.4.1 Key Strengths
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses & Competitive Threats
13.1.5 Aiforia Technologies Plc
13.1.5.1 Business Overview
13.1.5.2 Products/Services Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Deals
13.1.5.4 The Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses & Competitive Threats
13.1.6 Indica Labs Inc.
13.1.6.1 Business Overview
13.1.6.2 Products/Services Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product/Service Launches & Approvals
13.1.6.3.2 Deals
13.1.6.3.3 Expansions
13.1.7 Optrascan
13.1.7.1 Business Overview
13.1.7.2 Products/Services Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Other Developments
13.1.8 Ibex Medical Analytics Ltd.
13.1.8.1 Business Overview
13.1.8.2 Products/Services Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product/Service Launches & Approvals
13.1.8.3.2 Deals
13.1.9 Mindpeak Gmbh
13.1.9.1 Business Overview
13.1.9.2 Products/Services Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product/Service Launches & Approvals
13.1.9.3.2 Deals
13.1.9.3.3 Other Developments
13.1.10 Tribun Health
13.1.10.1 Business Overview
13.1.10.2 Products/Services Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Deals
13.1.11 Techcyte, Inc.
13.1.11.1 Business Overview
13.1.11.2 Products/Services Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Product/Service Launches & Approvals
13.1.11.3.2 Deals
13.1.11.3.3 Other Developments
13.1.12 Deep Bio Inc.
13.1.12.1 Business Overview
13.1.12.2 Products/Services Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Deals
13.1.13 Lumea Inc.
13.1.13.1 Business Overview
13.1.13.2 Products/Services Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Deals
13.1.14 Visiopharm
13.1.14.1 Business Overview
13.1.14.2 Products/Services Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Product/Service Launches & Approvals
13.1.14.3.2 Expansions
13.1.15 Aetherai
13.1.15.1 Business Overview
13.1.15.2 Products/Services Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Deals
13.1.16 Aiosyn
13.1.16.1 Business Overview
13.1.16.2 Products/Services Offered
13.1.16.3 Recent Developments
13.1.16.3.1 Product/Service Launches & Approvals
13.1.16.3.2 Deals
13.1.16.3.3 Other Developments
13.1.17 Paige Ai, Inc.
13.1.17.1 Business Overview
13.1.17.2 Products/Services Offered
13.1.17.3 Recent Developments
13.1.17.3.1 Product/Service Launches & Approvals
13.1.17.3.2 Deals
13.1.17.3.3 Other Developments
13.1.18 Proscia, Inc.
13.1.18.1 Business Overview
13.1.18.2 Products/Services Offered
13.1.18.3 Recent Developments
13.1.18.3.1 Product/Service Launches & Approvals
13.1.18.3.2 Deals
13.1.18.3.3 Other Developments
13.1.19 Pathai, Inc.
13.1.19.1 Business Overview
13.1.19.2 Products/Services Offered
13.1.19.3 Recent Developments
13.1.19.3.1 Product/Service Launches & Approvals
13.1.19.3.2 Deals
13.1.20 Tempus Labs, Inc.
13.1.20.1 Business Overview
13.1.20.2 Products/Services Offered
13.1.20.3 Recent Developments
13.1.20.3.1 Product/Service Launches & Approvals
13.2 Other Players
13.2.1 Konfoong Bioinformation Tech Co., Ltd.
13.2.2 Domore Diagnostics as
13.2.3 Qritive
13.2.4 Deepathology Ltd
13.2.5 4D Path Inc.

14.1 Discussion Guide
14.2 Knowledgestore: The Subscription Portal
14.3 Customization Options
14.4 Related Reports
14.5 Author Details

Table 1 Exchange Rates, 2021-2024
Table 2 Role of Players in Market Ecosystem
Table 3 Regulatory Bodies, Government Agencies, and Other Organizations
Table 4 Us Fda: Medical Device Classification
Table 5 Us: Medical Device Regulatory Approval Process
Table 6 Canada: Medical Device Regulatory Approval Process
Table 7 Europe: Classification of Ivd Devices
Table 8 Japan: Medical Device Classification Under Pmda
Table 9 China: Classification of Medical Devices
Table 10 Indicative Pricing Analysis, by Offering
Table 11 Impact of Porter’S Forces
Table 12 Jurisdiction Analysis of Top Applicants in Ai in Pathology Market
Table 13 Key Patents in Ai in Pathology Market
Table 14 Influence of Stakeholders on Buying Process, by End User (%)
Table 15 Key Buying Criteria, by End User
Table 16 Unmet Needs of End Users
Table 17 Ai in Pathology Market: End User Expectations
Table 18 List of Conferences and Events, 2025-2026
Table 19 Import Data for Hs Code 9011-Compliant Products, by Country, 2020-2023 (Usd Thousand)
Table 20 Export Data for Hs Code 9011-Compliant Products, by Country, 2020-2023 (Usd Million)
Table 21 Reciprocal Tariff Rates Adjusted by Us
Table 22 Tariff Rates for Ai in Pathology Products
Table 23 Expected Change in Prices and Their Impact on End User Products Due to Tariff Impact
Table 24 Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 25 Ai in Pathology Market for End-to-End Solutions, by Country/Region, 2023-2030 (Usd Million)
Table 26 Ai in Pathology Market for Niche Point Solutions, by Country/Region, 2023-2030 (Usd Million)
Table 27 Ai in Pathology Market for Technology, by Country/Region, 2023-2030 (Usd Million)
Table 28 Ai in Pathology Market for Hardware, by Type, 2023-2030 (Usd Million)
Table 29 Ai in Pathology Market for Hardware, by Country/Region, 2023-2030 (Usd Million)
Table 30 Ai in Pathology Market for Microscopes, by Country/Region, 2023-2030 (Usd Million)
Table 31 Ai in Pathology Market for Scanners, by Country/Region, 2023-2030 (Usd Million)
Table 32 Ai in Pathology Market for Storage Systems, by Country/Region, 2023-2030 (Usd Million)
Table 33 Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 34 Ai in Pathology Market for Convolutional Neural Networks, by Country/Region, 2023-2030 (Usd Million)
Table 35 Ai in Pathology Market for Generative Adversarial Networks, by Country/Region, 2023-2030 (Usd Million)
Table 36 Ai in Pathology Market for Recurrent Neural Networks, by Country/Region, 2023-2030 (Usd Million)
Table 37 Ai in Pathology Market for Other Neural Networks, by Country/Region, 2023-2030 (Usd Million)
Table 38 Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 39 Ai in Pathology Market for Image Analysis, by Country/Region, 2023-2030 (Usd Million)
Table 40 Ai in Pathology Market for Diagnostics, by Country/Region, 2023-2030 (Usd Million)
Table 41 Ai in Pathology Market for Workflow Management, by Country/Region, 2023-2030 (Usd Million)
Table 42 Ai in Pathology Market for Data Management, by Country/Region, 2023-2030 (Usd Million)
Table 43 Ai in Pathology Market for Predictive Analytics, by Country/Region, 2023-2030 (Usd Million)
Table 44 Ai in Pathology Market for Cdss, by Country/Region, 2023-2030 (Usd Million)
Table 45 Ai in Pathology Market for Automated Report Generation, by Country/Region, 2023-2030 (Usd Million)
Table 46 Ai in Pathology Market for Quality Assurance Tools, by Country/Region, 2023-2030 (Usd Million)
Table 47 Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 48 Drug Discovery Applications for Ai in Pathology
Table 49 Ai in Pathology Market for Drug Discovery, by Type, 2023-2030 (Usd Million)
Table 50 Ai in Pathology Market for Drug Discovery, by Country/Region, 2023-2030 (Usd Million)
Table 51 Ai in Pathology Market for Target Identification & Selection, by Country/Region, 2023-2030 (Usd Million)
Table 52 Ai in Pathology Market for Target Validation, by Country/Region, 2023-2030 (Usd Million)
Table 53 Ai in Pathology Market for Hit Identification & Prioritization, by Country/Region, 2023-2030 (Usd Million)
Table 54 Ai in Pathology Market for Hit-to-Lead Identification, by Country/Region, 2023-2030 (Usd Million)
Table 55 Ai in Pathology Market for Lead Optimization, by Country/Region, 2023-2030 (Usd Million)
Table 56 Ai in Pathology Market for Candidate Selection & Validation, by Country/Region, 2023-2030 (Usd Million)
Table 57 Ai in Pathology Market for Disease Diagnosis & Prognosis, by Country/Region, 2023-2030 (Usd Million)
Table 58 Ai in Pathology Market for Clinical Workflow, by Country/Region, 2023-2030 (Usd Million)
Table 59 Ai in Pathology Market for Training & Education, by Country/Region, 2023-2030 (Usd Million)
Table 60 Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 61 Ai in Pathology Market for Pharmaceutical & Biopharmaceutical Companies, by Country/Region, 2023-2030 (Usd Million)
Table 62 Ai in Pathology Market for Hospitals & Reference Laboratories, by Country/Region, 2023-2030 (Usd Million)
Table 63 Ai in Pathology Market for Academic & Research Institutes, by Country/Region, 2023-2030 (Usd Million)
Table 64 Ai in Pathology Market, by Region, 2023-2030 (Usd Million)
Table 65 North America: Ai in Pathology Market, by Country, 2023-2030 (Usd Million)
Table 66 North America: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 67 North America: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 68 North America: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 69 North America: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 70 North America: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 71 Us: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 72 Us: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 73 Us: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 74 Us: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 75 Us: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 76 Canada: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 77 Canada: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 78 Canada: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 79 Canada: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 80 Canada: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 81 Europe: Ai in Pathology Market, by Country/Region, 2023-2030 (Usd Million)
Table 82 Europe: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 83 Europe: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 84 Europe: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 85 Europe: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 86 Europe: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 87 Uk: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 88 Uk: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 89 Uk: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 90 Uk: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 91 Uk: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 92 Germany: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 93 Germany: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 94 Germany: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 95 Germany: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 96 Germany: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 97 France: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 98 France: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 99 France: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 100 France: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 101 France: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 102 Italy: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 103 Italy: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 104 Italy: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 105 Italy: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 106 Italy: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 107 Spain: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 108 Spain: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 109 Spain: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 110 Spain: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 111 Spain: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 112 Rest of Europe: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 113 Rest of Europe: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 114 Rest of Europe: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 115 Rest of Europe: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 116 Rest of Europe: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 117 Asia Pacific: Ai in Pathology Market, by Country/Region, 2023-2030 (Usd Million)
Table 118 Asia Pacific: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 119 Asia Pacific: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 120 Asia Pacific: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 121 Asia Pacific: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 122 Asia Pacific: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 123 China: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 124 China: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 125 China: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 126 China: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 127 China: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 128 Japan: Cancer Incidence, by Cancer Type, 2020 Vs. 2040
Table 129 Japan: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 130 Japan: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 131 Japan: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 132 Japan: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 133 Japan: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 134 India: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 135 India: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 136 India: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 137 India: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 138 India: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 139 Rest of Asia Pacific: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 140 Rest of Asia Pacific: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 141 Rest of Asia Pacific: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 142 Rest of Asia Pacific: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 143 Rest of Asia Pacific: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 144 Latin America: Ai in Pathology Market, by Country/Region, 2023-2030 (Usd Million)
Table 145 Latin America: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 146 Latin America: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 147 Latin America: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 148 Latin America: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 149 Latin America: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 150 Brazil: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 151 Brazil: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 152 Brazil: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 153 Brazil: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 154 Brazil: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 155 Mexico: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 156 Mexico: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 157 Mexico: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 158 Mexico: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 159 Mexico: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 160 Rest of Latin America: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 161 Rest of Latin America: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 162 Rest of Latin America: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 163 Rest of Latin America: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 164 Rest of Latin America: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 165 Middle East & Africa: Ai in Pathology Market, by Region, 2023-2030 (Usd Million)
Table 166 Middle East & Africa: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 167 Middle East & Africa: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 168 Middle East & Africa: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 169 Middle East & Africa: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 170 Middle East & Africa: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 171 Gcc Countries: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 172 Gcc Countries: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 173 Gcc Countries: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 174 Gcc Countries: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 175 Gcc Countries: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 176 Rest of Middle East & Africa: Ai in Pathology Market, by Offering, 2023-2030 (Usd Million)
Table 177 Rest of Middle East & Africa: Ai in Pathology Market, by Function, 2023-2030 (Usd Million)
Table 178 Rest of Middle East & Africa: Ai in Pathology Market, by Neural Network, 2023-2030 (Usd Million)
Table 179 Rest of Middle East & Africa: Ai in Pathology Market, by Use Case, 2023-2030 (Usd Million)
Table 180 Rest of Middle East & Africa: Ai in Pathology Market, by End User, 2023-2030 (Usd Million)
Table 181 Overview of Strategies Deployed by Key Companies
Table 182 Ai in Pathology Market: Degree of Competition
Table 183 Offering Footprint
Table 184 Use Case Footprint
Table 185 End User Footprint
Table 186 Region Footprint
Table 187 Ai in Pathology Market: Detailed List of Key Startups/Smes
Table 188 Ai in Pathology Market: Competitive Benchmarking of Key Startups/Smes
Table 189 Ai in Pathology Market: Product/Service Launches & Approvals, January 2021-April 2025
Table 190 Ai in Pathology Market: Deals, January 2021-April 2025
Table 191 Ai in Pathology Market: Other Developments, January 2021- April 2025
Table 192 Koninklijke Philips N.V.: Company Overview
Table 193 Koninklijke Philips N.V.: Products/Services Offered
Table 194 Koninklijke Philips N.V.: Deals, January 2021-April 2025
Table 195 F. Hoffmann-La Roche Ltd.: Company Overview
Table 196 F. Hoffmann La Roche Ltd.: Products/Services Offered
Table 197 F. Hoffmann-La Roche Ltd.: Product/Service Launches & Approvals, January 2021-March 2025
Table 198 F. Hoffmann-La Roche Ltd.: Deals, January 2021-March 2025
Table 199 Hologic, Inc.: Company Overview
Table 200 Hologic, Inc.: Products/Services Offered
Table 201 Hologic, Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 202 Akoya Biosciences, Inc.: Company Overview
Table 203 Akoya Biosciences, Inc.: Product/Services Offered
Table 204 Akoya Biosciences, Inc.: Deals, January 2021-April 2025
Table 205 Aiforia Technologies Plc: Company Overview
Table 206 Aiforia Technologies Plc: Product/Services Offered
Table 207 Aiforia Technologies Plc: Deals, January 2021-April 2025
Table 208 Indica Labs Inc.: Company Overview
Table 209 Indica Labs Inc.: Products/Services Offered
Table 210 Indica Labs Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 211 Indica Labs Inc.: Deals, January 2021-April 2025
Table 212 Indica Labs Inc.: Expansions, January 2021-April 2025
Table 213 Optrascan: Company Overview
Table 214 Optrascan: Products/Services Offered
Table 215 Optrascan: Other Developments, January 2021-April 2025
Table 216 Ibex Medical Analytics Ltd.: Company Overview
Table 217 Ibex Medical Analytics Ltd.: Products/Services Offered
Table 218 Ibex Medical Analytics Ltd.: Product/Service Launches & Approvals, January 2021-April 2025
Table 219 Ibex Medical Analytics Ltd: Deals, January 2021-April 2025
Table 220 Mindpeak Gmbh: Company Overview
Table 221 Mindpeak Gmbh: Products/Services Offered
Table 222 Mindpeak Gmbh: Product/Service Launches & Approvals, January 2021-April 2025
Table 223 Mindpeak Gmbh: Deals, January 2021-April 2025
Table 224 Mindpeak Gmbh: Other Developments, January 2021-April 2025
Table 225 Tribun Health: Company Overview
Table 226 Tribun Health: Products/Services Offered
Table 227 Tribun Health: Deals, January 2021-April 2025
Table 228 Techcyte, Inc.: Company Overview
Table 229 Techcyte, Inc.: Products/Services Offered
Table 230 Techcyte, Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 231 Techcyte, Inc.: Deals, January 2021-April 2025
Table 232 Techcyte, Inc.: Other Developments, January 2021-April 2025
Table 233 Deep Bio Inc.: Company Overview
Table 234 Deep Bio Inc.: Products/Services Offered
Table 235 Deep Bio Inc.: Deals, January 2021-April 2025
Table 236 Lumea Inc.: Company Overview
Table 237 Lumea Inc.: Products/Services Offered
Table 238 Lumea Inc.: Deals, January 2021-April 2025
Table 239 Visiopharm: Company Overview
Table 240 Visiopharm: Products/Services Offered
Table 241 Visiopharm: Product/Service Launches & Approvals, January 2021-April 2025
Table 242 Visiopharm: Expansions, January 2021- April 2025
Table 243 Aetherai: Company Overview
Table 244 Aetherai: Products/Services Offered
Table 245 Aetherai: Deals, January 2021- April 2025
Table 246 Aiosyn: Company Overview
Table 247 Aiosyn: Products/Services Offered
Table 248 Aiosyn: Product/Service Launches & Approvals, January 2021-April 2025
Table 249 Aiosyn: Deals, January 2021-April 2025
Table 250 Aiosyn: Other Developments, January 2021-April 2025
Table 251 Paige Ai, Inc.: Company Overview
Table 252 Paige Ai, Inc.: Products/Services Offered
Table 253 Paige Ai, Inc.: Product/Service Launches & Approvals, January 2021- April 2025
Table 254 Paige Ai, Inc.: Deals, January 2021-April 2025
Table 255 Paige Ai, Inc.: Other Developments, January 2021-April 2025
Table 256 Proscia, Inc.: Company Overview
Table 257 Proscia, Inc.: Products/Services Offered
Table 258 Proscia, Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 259 Proscia, Inc.: Deals, January 2021-April 2025
Table 260 Proscia, Inc.: Other Developments, January 2021-April 2025
Table 261 Pathai, Inc.: Company Overview
Table 262 Pathai, Inc.: Products/Services Offered
Table 263 Pathai, Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 264 Pathai, Inc.: Deals, January 2021-April 2025
Table 265 Tempus Labs, Inc.: Company Overview
Table 266 Tempus Labs, Inc.: Products/Services Offered
Table 267 Tempus Labs, Inc.: Product/Service Launches & Approvals, January 2021-April 2025
Table 268 Konfoong Bioinformation Tech Co., Ltd.: Company Overview
Table 269 Domore Diagnostics as: Company Overview
Table 270 Qritive: Company Overview
Table 271 Deeppath: Company Overview
Table 272 4D Path Inc.: Company Overview

Figure 1 Research Design
Figure 2 Key Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side): by Company Type, Designation, and Region
Figure 4 Market Size Estimation Process
Figure 5 Key Insights From Industry Experts
Figure 6 Bottom-Up Approach: End User Spending on Ai in Pathology
Figure 7 Ai in Pathology Market: CAGR Projections From Analysis of Drivers, Restraints, Opportunities, and Challenges (2025-2030)
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Top-Down Approach
Figure 10 Data Triangulation Methodology
Figure 11 Ai in Pathology Market, by Offering, 2025 Vs. 2030 (Usd Million)
Figure 12 Ai in Pathology Market, by Neural Network, 2025 Vs. 2030 (Usd Million)
Figure 13 Ai in Pathology Market, by Use Case, 2025 Vs. 2030 (Usd Million)
Figure 14 Ai in Pathology Market, by End User, 2025 Vs. 2030 (Usd Million)
Figure 15 Ai in Pathology Market: Geographic Snapshot
Figure 16 Development of Convolutional Neural Networks (Cnns) and Ai Learning Models to Propel Market
Figure 17 North America to Lead Market During Forecast Period
Figure 18 Pharmaceutical & Biopharmaceutical Companies Segment and China Accounted for Significant Share in 2024
Figure 19 India to Register Highest Growth During Forecast Period
Figure 20 Ai in Pathology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Healthcare Breaches Reported to Us Department of Health and Human Services (September 2024)
Figure 22 Trends & Disruptions Impacting Customer Business
Figure 23 Ecosystem Analysis
Figure 24 Value Chain Analysis
Figure 25 Europe: Ivdr Timeline
Figure 26 Porter’S Five Forces
Figure 27 Number of Patents Published, January 2017-April 2025
Figure 28 Number of Patent Documents, by Jurisdiction
Figure 29 Top Patent Applicants and Owners (Companies/Institutions), January 2017-April 2025
Figure 30 Influence of Stakeholders on Buying Process, by End User
Figure 31 Key Buying Criteria, by End User
Figure 32 Funding Activities in Ai in Pathology Market
Figure 33 Market Potential of Ai/Generative Ai in Pathology
Figure 34 Import Data for Hs Code 9011-Compliant Products, by Country, 2020-2023 (Usd)
Figure 35 Export Data for Hs Code 9011-Compliant Products, by Country, 2020-2023 (Usd Thousand)
Figure 36 North America: Ai in Pathology Market Snapshot
Figure 37 Asia Pacific: Ai in Pathology Market Snapshot
Figure 38 Revenue Analysis of Key Players, 2020-2024 (Usd Million)
Figure 39 Ai in Pathology Market: Market Share Analysis (2024)
Figure 40 Ai in Pathology Market: Company Evaluation Matrix (Key Players), 2024
Figure 41 Ai in Pathology Market: Company Footprint
Figure 42 Ai in Pathology Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 43 Ev/Ebitda of Key Vendors
Figure 44 Ytd Price Total Return and 5-Year Stock Beta of Ai in Pathology Vendors
Figure 45 Brand/Product Comparison
Figure 46 Koninklijke Philips N.V.: Company Snapshot (2024)
Figure 47 F. Hoffmann-La Roche Ltd.: Company Snapshot (2024)
Figure 48 Hologic, Inc.: Company Snapshot (2024)
Figure 49 Akoya Biosciences, Inc.: Company Snapshot (2023)
Figure 50 Aiforia Technologies Plc: Company Snapshot (2024)
Figure 51 Tempus: Company Snapshot (2024)